MA28932B1 - Composes tricycliques contenant des heteroatomes - Google Patents

Composes tricycliques contenant des heteroatomes

Info

Publication number
MA28932B1
MA28932B1 MA29826A MA29826A MA28932B1 MA 28932 B1 MA28932 B1 MA 28932B1 MA 29826 A MA29826 A MA 29826A MA 29826 A MA29826 A MA 29826A MA 28932 B1 MA28932 B1 MA 28932B1
Authority
MA
Morocco
Prior art keywords
heteroatomes
compounds containing
tricyclic compounds
tricyclic
containing heteroatomes
Prior art date
Application number
MA29826A
Other languages
English (en)
Inventor
Maximilian Grassberger
Amarylla Horvath
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422643A external-priority patent/GB0422643D0/en
Priority claimed from GB0427599A external-priority patent/GB0427599D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA28932B1 publication Critical patent/MA28932B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
MA29826A 2004-10-12 2007-04-12 Composes tricycliques contenant des heteroatomes MA28932B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0422643A GB0422643D0 (en) 2004-10-12 2004-10-12 Organic compounds
GB0427599A GB0427599D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
MA28932B1 true MA28932B1 (fr) 2007-10-01

Family

ID=36084355

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29826A MA28932B1 (fr) 2004-10-12 2007-04-12 Composes tricycliques contenant des heteroatomes

Country Status (28)

Country Link
US (1) US7514554B2 (fr)
EP (1) EP1802635B8 (fr)
JP (1) JP5032326B2 (fr)
KR (1) KR101228188B1 (fr)
CN (1) CN101031573B (fr)
AR (1) AR051386A1 (fr)
AU (1) AU2005293799B2 (fr)
BR (1) BRPI0516873A (fr)
CA (1) CA2581046C (fr)
DK (1) DK1802635T3 (fr)
EC (1) ECSP077384A (fr)
ES (1) ES2389206T3 (fr)
GT (1) GT200500282A (fr)
HK (1) HK1105634A1 (fr)
IL (1) IL182307A (fr)
JO (1) JO2727B1 (fr)
MA (1) MA28932B1 (fr)
MX (1) MX2007004258A (fr)
MY (1) MY140880A (fr)
NO (1) NO338603B1 (fr)
NZ (1) NZ554010A (fr)
PE (1) PE20060581A1 (fr)
PL (1) PL1802635T3 (fr)
PT (1) PT1802635E (fr)
RU (1) RU2394037C2 (fr)
TN (1) TNSN07133A1 (fr)
TW (1) TWI361192B (fr)
WO (1) WO2006040111A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI315310B (en) * 2004-12-01 2009-10-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of preparing pimecrolimus
IT1394309B1 (it) 2009-05-22 2012-06-06 Poli Ind Chimica Spa Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus
EP3178824A1 (fr) 2015-12-08 2017-06-14 Medichem, S.A. Procédé de préparation de pimecrolimus
CN106854228B (zh) * 2015-12-08 2020-05-29 博瑞生物医药(苏州)股份有限公司 一种吡美莫司的制备方法
PL3619215T3 (pl) 2017-05-01 2022-03-21 Meda Pharma Gmbh & Co. Kg Sposób przekształcania surowej askomycyny w oczyszczony pimecrolimus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464366A (en) * 1979-12-19 1984-08-07 Ciba Geigy Corporation Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
ATE126803T1 (de) * 1989-11-09 1995-09-15 Sandoz Ag Heteroatome enthaltende tricyclische verbindungen.
EP0480623A1 (fr) 1990-10-11 1992-04-15 Merck & Co. Inc. Halomacrolides et dérivés ayant une activité immunosuppressive
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US6160117A (en) * 1997-11-06 2000-12-12 Zeneca Limited Chemical process
GB0012383D0 (en) * 2000-05-22 2000-07-12 Novartis Ag Organic compounds
US6667312B2 (en) * 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines

Also Published As

Publication number Publication date
EP1802635B1 (fr) 2012-06-06
EP1802635B8 (fr) 2013-04-17
GT200500282A (es) 2006-05-04
CN101031573B (zh) 2010-06-09
PT1802635E (pt) 2012-08-21
NO20072127L (no) 2007-06-08
JP2008515945A (ja) 2008-05-15
US7514554B2 (en) 2009-04-07
AR051386A1 (es) 2007-01-10
CA2581046C (fr) 2013-03-26
IL182307A0 (en) 2007-09-20
ES2389206T3 (es) 2012-10-24
JO2727B1 (en) 2013-09-15
TW200626603A (en) 2006-08-01
DK1802635T3 (da) 2012-09-10
WO2006040111A3 (fr) 2006-06-22
NO338603B1 (no) 2016-09-12
IL182307A (en) 2011-06-30
KR20070063535A (ko) 2007-06-19
PL1802635T3 (pl) 2013-07-31
NZ554010A (en) 2009-10-30
AU2005293799B2 (en) 2009-02-26
ECSP077384A (es) 2007-05-30
CN101031573A (zh) 2007-09-05
MY140880A (en) 2010-01-29
RU2394037C2 (ru) 2010-07-10
WO2006040111A2 (fr) 2006-04-20
CA2581046A1 (fr) 2006-04-20
PE20060581A1 (es) 2006-08-17
JP5032326B2 (ja) 2012-09-26
TNSN07133A1 (en) 2008-11-21
TWI361192B (en) 2012-04-01
RU2007117497A (ru) 2008-11-20
BRPI0516873A (pt) 2008-09-23
MX2007004258A (es) 2007-05-11
AU2005293799A1 (en) 2006-04-20
EP1802635A2 (fr) 2007-07-04
HK1105634A1 (en) 2008-02-22
KR101228188B1 (ko) 2013-01-30
US20080071082A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
MA28357A1 (fr) Composes
DE602005024010D1 (de) Behälter
DE602006018724D1 (de) Terie des beuteltyps
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
MA28932B1 (fr) Composes tricycliques contenant des heteroatomes
BRPI0511620A (pt) gaseificador aperfeiçoado
DK1948126T3 (da) Oral sammensætning indeholdende morin
ATE411027T1 (de) Benzazepin-derivate als mao-b-hemmer
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
ITTO20040494A1 (it) Container telonato
SE0402103D0 (sv) Novel compounds
SE0400022D0 (sv) New compounds
TH83855B (th) " พาน "
SE0400254D0 (sv) New compounds
ITUD20040152A1 (it) Contenitore migliorato
SE0401821D0 (sv) Chemical compounds
SE0401420D0 (sv) Chemical compounds
SE0401907D0 (sv) Chemical compounds
SE0401822D0 (sv) Chemical compounds
SE0403054D0 (sv) Novel compounds
SE0401885D0 (sv) Novel compounds
SE0400286D0 (sv) Novel Compounds
SE0401348D0 (sv) Novel compounds
SE0402068D0 (sv) Novel compounds
SE0402069D0 (sv) Novel compounds